
In the second part of a two-part interview, Paz Vellanki of Precision for Medicine explains which confirmatory evidence can support a single-trial approval and why she expects FDA's rare disease framework to last.
2020’s Pharma Manufacturing Trends The world of pharmaceutical manufacturing is changing fast Learn how today’s top pharmaceutical manufacturers are innovating







